Call 1 (888) 460-6556 to speak with a counselor.

Authors: Yokell MA, Zaller ND, Green TC, Rich JD
Abstract
The diversion, misuse, and non-medically supervised use of buprenorphine and buprenorphine/naloxone by opioid users are reviewed. Buprenorphine and buprenorphine/naloxone are used globally as opioid analgesics and in the treatment of opioid dependency. Diversion of buprenorphine and buprenorphine/naloxone represents a complex medical and social issue, and has been widely documented in various geographical regions throughout the world. We first discuss the clinical properties of buprenorphine and its abuse potential. Second, we discuss its diversion and illicit use on an international level, as well as motivations for those activities. Third, we examine the medical risks and benefits of buprenorphine’s non-medically supervise…

{ Comments on this entry are closed }

Call 1 (888) 460-6556 to speak with a counselor.

Authors: Soyka M
Abstract
Opioid maintenance therapy with methadone or buprenorphine is an established and first-line treatment for opioid dependence. Risk of diversion and toxicity of opioid prescription drugs, including buprenorphine, causes significant concerns. This is particularly the case in the United States, where the number of related emergency visits is increasing, especially in children. A systematic literature research (Medline, Pubmed) was performed to assess the risk associated with buprenorphine. The search, which was not limited to particular publication years, was performed with the key words buprenorphine AND toxicity (114 counts ) AND children (4 counts) and buprenorphine AND mortality AND children (5 counts). In addition, the author obtained information from rel…

MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…

{ Comments on this entry are closed }

Complete Care Medical Center Now Offering Outpatient Detox Treatment…

November 11, 2014

Complete Care Medical Center is now offering outpatient detox treatment with several Certified Suboxone Doctors in South Florida. The treatment is highly effective for those suffering from addiction…(PRWeb November 11, 2014)Read the full story at http://www.prweb.com/releases/suboxone-doctors/south-florida/prweb12317157.htm (Source: PRWeb: Medical Pharmaceuticals) MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…

Read the full article →

Combined Abuse of Clonidine and Amitriptyline in a Patient on Buprenorphine Maintenance Treatment

November 1, 2014

Buprenorphine/naloxone maintenance therapy is often prescribed in primary care to treat opioid dependence. Previous reports have described concomitant abuse of opioids and clonidine. In this case, a primary care patient on buprenorphine/naloxone maintenance therapy demonstrating altered mental status, hallucinations, falls, and rebound hypertension was found to be concomitantly abusing clonidine and amitryptyline, which share metabolic […]

Read the full article →

Group Medication Management for Buprenorphine/Naloxone in Opioid-Dependent Veterans

November 1, 2014

Conclusions:This study found that veterans prescribed buprenorphine/naloxone in a group setting as part of a drug and alcohol treatment program were retained in treatment longer than veterans prescribed this medication individually. Because of inherent limitations in the study design, no causality can be determined; however, given the results found here, group medication management of buprenorphine/naloxone […]

Read the full article →

Diversion of Methadone and Buprenorphine by Patients in Opioid Substitution Treatment in Sweden: Prevalence Estimates and Risk Factors

October 28, 2014

Dependence on heroin or other opiates is a condition which is difficult to treat. Research has been unable to point to any clear evidence of lasting effects of medication-free treatment. The dominant treatment method is opioid substitution treatment (OST) with methadone or buprenorphine, the latter often combined with naloxone. Metastudies show that OST is effective […]

Read the full article →

Opioid Addicted Buprenorphine Injectors: Drug Use During And After 12-weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia

October 19, 2014

Assess the prevalence of non-opioid drug use among opioid-addicted, buprenorphine injecting individuals in Georgia, during and after a 12-week course of buprenorphine-naloxone (Suboxone®) or methadone. (Source: Journal of Substance Abuse Treatment) MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…

Read the full article →

Diffusion and diversion of suboxone: an exploration of illicit street opioid selling – Terry Furst R.

October 9, 2014

[Abstract unavailable] Language: en… (Source: SafetyLit: All (Unduplicated)) MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Read the full article →

Buprenorphine-Naloxone Therapy in Pain Management

October 1, 2014

No abstract available (Source: Survey of Anesthesiology) MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Read the full article →

Table of Contents

September 26, 2014

Abstract SAMHSA Buprenorphine Meeting: Another Step Toward Lifting the Cap Fraud Probe of Sober Homes Highlights Drug‐Test Scams Bill Proposed to Provide Local Incentives to Treat Addiction N.J. Bill Would Allow Outpatient Commitment for Addiction California Certification: CAADAC + CAARR = CCAPP NASADAD Issues Public Policy Statement Endorsing Naloxone ASAM Revises Public Policy Statement on […]

Read the full article →